DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513.64B
Enterprise Value 318.11B
Trailing P/E 19.43
Forward P/E 114.92
PEG Ratio (5 yr expected) 12.91
Price/Sales (ttm)1.81
Price/Book (mrq)2.57
Enterprise Value/Revenue 32.40
Enterprise Value/EBITDA 612.06

Trading Information

Stock Price History

Beta (3Y Monthly) 0.89
52-Week Change 3-10.93%
S&P500 52-Week Change 37.06%
52 Week High 3115.64
52 Week Low 378.95
50-Day Moving Average 3100.37
200-Day Moving Average 392.15

Share Statistics

Avg Vol (3 month) 31.02M
Avg Vol (10 day) 3710.3k
Shares Outstanding 5134.58M
Float 133.75M
% Held by Insiders 10.35%
% Held by Institutions 191.55%
Shares Short (Jun 28, 2019) 44.53M
Short Ratio (Jun 28, 2019) 45.16
Short % of Float (Jun 28, 2019) 43.80%
Short % of Shares Outstanding (Jun 28, 2019) 43.37%
Shares Short (prior month May 31, 2019) 44.54M

Dividends & Splits

Forward Annual Dividend Rate 42.12
Forward Annual Dividend Yield 42.10%
Trailing Annual Dividend Rate 32.06
Trailing Annual Dividend Yield 32.04%
5 Year Average Dividend Yield 41.93
Payout Ratio 439.46%
Dividend Date 3Jul 22, 2019
Ex-Dividend Date 4Jul 5, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 21, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 9.59%
Operating Margin (ttm)15.68%

Management Effectiveness

Return on Assets (ttm)6.53%
Return on Equity (ttm)14.68%

Income Statement

Revenue (ttm)7.54B
Revenue Per Share (ttm)55.63
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)2.67B
EBITDA 1.5B
Net Income Avi to Common (ttm)720M
Diluted EPS (ttm)5.22
Quarterly Earnings Growth (yoy)-7.30%

Balance Sheet

Total Cash (mrq)464M
Total Cash Per Share (mrq)3.45
Total Debt (mrq)4.85B
Total Debt/Equity (mrq)89.59
Current Ratio (mrq)0.78
Book Value Per Share (mrq)39.48

Cash Flow Statement

Operating Cash Flow (ttm)1.3B
Levered Free Cash Flow (ttm)638.25M